An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.

Background and Aim: Medical treatment of steroid-refractory ulcerative colitis (UC) is limited to either cyclosporine or infliximab. Studies comparing cyclosporine with either placebo or ...

Background/Aims Infliximab is currently used for the treatment of moderate-to-severe ulcerative colitis (UC) with an inadequate response to conventional agents. The efficacy and safety of ...

The success of infliximab paved the way for the introduction of other drugs with a similar mechanism of action. Three other TNF-blocking agents (etanercept, adalimumab and certolizumab pegol) are ...

FutureWise Research, a leading provider of market intelligence and consulting services in the healthcare industry, is pleased to announce the release of its latest in-depth market analysis report, ...

“Anti-MCV antibodies might, therefore, be useful in monitoring response to infliximab therapy...” After adjustment of the anti-MCV assay to produce the same specificity as the anti-CCP assay ...

A retrospective study from a single inflammatory bowel disease (IBD) center in Greece reported that from 2018 to 2022, the ...

Their brain scans also showed changes in areas that help control motivation, including the prefrontal cortex and the ventral striatum. These changes suggest that the drug might be helping the brain ...